Armata Pharmaceuticals (ARMP) Gross Profit: 2013-2024
Historic Gross Profit for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$5.6 million.
- Armata Pharmaceuticals' Gross Profit fell 1785.00% to -$337,000 in Q4 2018 from the same period last year, while for Dec 2018 it was -$712,000, marking a year-over-year decrease of 719.13%. This contributed to the annual value of -$5.6 million for FY2024, which is 392.59% down from last year.
- Armata Pharmaceuticals' Gross Profit amounted to -$5.6 million in FY2024, which was down 392.59% from $1.9 million recorded in FY2023.
- In the past 5 years, Armata Pharmaceuticals' Gross Profit ranged from a high of $5.5 million in FY2022 and a low of -$5.6 million during FY2024.
- Moreover, its 3-year median value for Gross Profit was $1.9 million (2023), whereas its average is $614,333.
- In the last 5 years, Armata Pharmaceuticals' Gross Profit surged by 2,143.08% in 2021 and then plummeted by 392.59% in 2024.
- Over the past 5 years, Armata Pharmaceuticals' Gross Profit (Yearly) stood at $195,000 in 2020, then surged by 2,143.08% to $4.4 million in 2021, then rose by 25.93% to $5.5 million in 2022, then slumped by 65.45% to $1.9 million in 2023, then crashed by 392.59% to -$5.6 million in 2024.